Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Exp Neurol. 2014 May 2;257:170–181. doi: 10.1016/j.expneurol.2014.04.024

Figure 3. Sub-lethal 6OHDA reduces EB1 levels.

Figure 3

SH-SY5Y cells were treated with sub-lethal 6OHDA and EB1 levels were analyzed via immunocytochemistry and Western blotting. (A) Two sets of representative images are shown where reduced EB1 staining is noted along the length of the neurite in 6OHDA-treated cells. (B) Western blot of total cellular EB1 levels showed a reduction with 6OHDA treatment. Mean +/− SEM, *p < 0.05 vs. Veh. Cont.